The Chan Zuckerberg Initiative has released two new funding announcements.
- The Ben Barres Early Career Acceleration Award (LOI open now, from March 16 - April 20, 2023), an investigator award for early-career academic investigators, especially those who are new to the field of neurodegeneration. Awards are $1.2 M in total costs over 4 years, and early career investigators will benefit from mentored support and resources of the CZI Neurodegeneration Challenge Network.
- The NDCN Collaborative Pairs Pilot Project Award (LOI to open from May 9 - June 22, 2023; stay tuned to the RFA page link for more details in May). Launching in May, this award supports collaborative pilot projects between two investigators who have not received prior funding together to explore innovative, interdisciplinary projects aimed at advancing key challenges in the field. Now in its second cycle, this program will continue to support research into neurodegenerative disease. In addition, with the view that elucidating fundamental mechanisms of brain function and their maintenance during healthy development & aging will be critical to a better understanding of neurodegenerative disease, this program will also support fundamental neuroscience investigations, with a particular focus on circuit-level mechanisms of brain function and sleep biology. One investigator from the collaborative team should be either an early-career or a mid-career investigator. Awards are $200,000 in total costs per pair, and successful pilots will be eligible to apply for additional four-year project development grants.
Please use this link to learn more and to apply: Apply Now: Ben Barres Early Career Acceleration Award RFA (chanzuckerberg.com)